Literature DB >> 10497882

Evidence for the involvement of the fatty acid and peroxisomal beta-oxidation pathways in the inhibition by dehydroepiandrosterone (DHEA) and induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and benz(a)anthracene (BA) of cytochrome P4501B1 (CYP1B1) in mouse embryo fibroblasts (C3H10T1/2 cells).

F I Ikegwuonu1, C R Jefcoate.   

Abstract

Treatment of intact C3H10T1/2 cells or microsomes therefrom with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and benzanthracene (BA) enhanced CYP1B1 activity and CYP1B1 expression as revealed by elevations of CYP1B1-catalyzed DMBA metabolism, CYP1B1 apoprotein level and CYP1B1 gene expression. One hundred microM DHEA caused an 80-90% inhibition of cellular DMBA metabolism without inflicting cell death. Cytosolic glucose-6-phosphate dehydrogenase (G6PDH) was also inhibited in DHEA-treated cells, presumably due to the inhibition of NADP reduction. In contrast, neither DMBA metabolism nor CYP1B1 apoprotein was inhibited by DHEA in the microsomes isolated from these cells. DHEA (100 microM), TCDD (10 nM) and BA (10 microM) stimulated the activities and increased the apoprotein levels of two peroxisomal enzymes, namely, acyl CoA oxidase (ACOX) and acyl CoA hydrolase (ACH2) and also induced the expression of CYP1B1 and ACOX genes. Cytosolic fatty acyl-CoA beta-oxidation was also stimulated by DHEA, TCDD and BA. In corroboratory experiments, it was found that concomitant with the stimulation of the activity of a key enzyme regulator of fatty acid homeostasis, namely, glycerol-3-phosphate dehydrogenase (G3PDH), these agents enhanced arachidonic acid (AA) metabolism as judged by the release of [3H] from AA into the culture medium. Collectively, these data suggest that DHEA mediates the regulation of CYP1B1 and inhibits BA and TCDD-induced CYP1B1-catalyzed carcinogen (DMBA) activation in 10T1/2 cells through metabolic interactions that involve the activation of the peroxisomal and fatty acid beta-oxidation signaling pathways. These results also present evidence for the first time, for the possible peroxisomal effects of TCDD and BA which are similar to those of DHEA in this mouse embryo fibroblast cell line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497882     DOI: 10.1023/a:1006954216233

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  49 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Purification and properties of long-chain acyl-CoA hydrolases from the liver cytosol of rats treated with peroxisome proliferator.

Authors:  J Yamada; I Matsumoto; T Furihata; M Sakuma; T Suga
Journal:  Arch Biochem Biophys       Date:  1994-01       Impact factor: 4.013

3.  Assay of peroxisomal beta-oxidation of fatty acids.

Authors:  P B Lazarow
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

4.  Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polycyclic aromatic hydrocarbons and hormones.

Authors:  M Christou; U Savas; S Schroeder; X Shen; T Thompson; M N Gould; C R Jefcoate
Journal:  Mol Cell Endocrinol       Date:  1995-11-30       Impact factor: 4.102

5.  Regulation of the immune response by dehydroepiandrosterone and its metabolites.

Authors:  R M Loria; D A Padgett; P N Huynh
Journal:  J Endocrinol       Date:  1996-09       Impact factor: 4.286

6.  Induction of a novel long-chain acyl-CoA hydrolase in rat liver by administration of peroxisome proliferators.

Authors:  S Miyazawa; S Furuta; T Hashimoto
Journal:  Eur J Biochem       Date:  1981-07

7.  Dehydroepiandrosterone 3 beta-sulphate is an endogenous activator of the peroxisome-proliferation pathway: induction of cytochrome P-450 4A and acyl-CoA oxidase mRNAs in primary rat hepatocyte culture and inhibitory effects of Ca(2+)-channel blockers.

Authors:  P A Ram; D J Waxman
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

8.  Dual regulation of cytochrome P450EF expression via the aryl hydrocarbon receptor and protein stabilization in C3H/10T1/2 cells.

Authors:  U Savas; C R Jefcoate
Journal:  Mol Pharmacol       Date:  1994-06       Impact factor: 4.436

9.  Sex differences in the twenty-four-hour mean plasma concentrations of dehydroisoandrosterone (DHA) and dehydroisoandrosterone sulfate (DHAS) and the DHA to DHAS ratio in normal adults.

Authors:  B Zumoff; R S Rosenfeld; G W Strain; J Levin; D K Fukushima
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958

10.  Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.

Authors:  S Li; X Yan; A Bélanger; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1994-02       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.